» Articles » PMID: 22832159

Long Telomeres Bypass the Requirement for Telomere Maintenance in Human Tumorigenesis

Overview
Journal Cell Rep
Publisher Cell Press
Date 2012 Jul 27
PMID 22832159
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the importance of telomere maintenance in cancer cell survival via the elongation of telomeres by telomerase reverse transcriptase (TERT) or alternative lengthening of telomeres (ALT), it had not been tested directly whether telomere maintenance is dispensable for human tumorigenesis. We engineered human tumor cells containing loxP-flanked hTERT to enable extensive telomere elongation prior to complete hTERT excision. Despite unabated telomere erosion, hTERT-excised cells formed tumors in mice and proliferated in vitro for up to 1 year. Telomerase reactivation or ALT was not observed, and the eventual loss of telomeric signal coincided with loss of tumorigenic potential and cell viability. Crisis was averted via the reintroduction of active but not inactive hTERT. Thus, telomere maintenance is dispensable for human tumorigenesis when telomere reserves are long. Yet, despite telomere instability and the presence of oncogenic RAS, human tumors remain susceptible to crisis induced by critically short telomeres.

Citing Articles

The complex interplay between aging and cancer.

Trastus L, dAdda di Fagagna F Nat Aging. 2025; .

PMID: 40038418 DOI: 10.1038/s43587-025-00827-z.


Telomerase-Mediated Anti-Ageing Interventions.

L Dunn P, Logeswaran D, Chen J Subcell Biochem. 2024; 107:1-20.

PMID: 39693017 DOI: 10.1007/978-3-031-66768-8_1.


Tieing together loose ends: telomere instability in cancer and aging.

Borges G, Criqui M, Harrington L Mol Oncol. 2022; 16(18):3380-3396.

PMID: 35920280 PMC: 9490142. DOI: 10.1002/1878-0261.13299.


POT1 Regulates Proliferation and Confers Sexual Dimorphism in Glioma.

Jalali A, Yu K, Beechar V, Bosquez Huerta N, Grichuk A, Mehra D Cancer Res. 2021; 81(10):2703-2713.

PMID: 33782098 PMC: 8243722. DOI: 10.1158/0008-5472.CAN-20-3755.


is a haploinsufficient tumor suppressor that limits telomere length.

Schmutz I, Mensenkamp A, Takai K, Haadsma M, Spruijt L, de Voer R Elife. 2020; 9.

PMID: 33258446 PMC: 7707837. DOI: 10.7554/eLife.61235.


References
1.
Tatsumoto N, Hiyama E, Murakami Y, Imamura Y, Shay J, Matsuura Y . High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res. 2000; 6(7):2696-701. View

2.
Parkinson E, Fitchett C, Cereser B . Dissecting the non-canonical functions of telomerase. Cytogenet Genome Res. 2009; 122(3-4):273-80. DOI: 10.1159/000167813. View

3.
Fattah K, Ruis B, Hendrickson E . Mutations to Ku reveal differences in human somatic cell lines. DNA Repair (Amst). 2008; 7(5):762-74. PMC: 2427147. DOI: 10.1016/j.dnarep.2008.02.008. View

4.
Hahn W, Stewart S, Brooks M, York S, Eaton E, Kurachi A . Inhibition of telomerase limits the growth of human cancer cells. Nat Med. 1999; 5(10):1164-70. DOI: 10.1038/13495. View

5.
Weinstein I, Joe A . Oncogene addiction. Cancer Res. 2008; 68(9):3077-80. DOI: 10.1158/0008-5472.CAN-07-3293. View